Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese

Inflammation Research

Volumn 60, Issue 1, 2011, Pages 63-68

  Wang, Bangqiong ^a   Li, Qifu ^a   Jiang, Yuanjuan ^a   Liu, Zhoujun ^a   Zhong, Li ^a   Luo, Rong ^a   Cheng, Qingfeng ^a   Qing, Hua ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

C reactive protein; Complement C3; Insulin resistance

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CHINESE; CHOLESTEROL BLOOD LEVEL; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMPLEMENT C3; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 78651366294     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0236-y     Document Type: Article

References (26)

1. M Pyorala H Miettinen P Halonen M Laakso K Pyorala 2002 Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Arterioscler Thromb Vasc Biol 20 538 544
2. W Lee J Park S Noh E Rhee K Sung B Kim, et al. 2004 C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report Int J Cardiol 97 101 106 10.1016/j.ijcard.2003.08. 016 15336815
3. P Dandona A Aljada A Bandyopadhyay 2004 Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 4 7 1:CAS:528:DC%2BD3sXhtVSjtL7N 10.1016/j.it.2003.10.013 14698276
4. A Muscari S Antonelli G Bianchi G Cavrini S Dapporto A Ligabue, et al. 2007 Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate Diabetes Care 30 2362 2368 1:CAS:528:DC%2BD2sXhtV2mu7vI 10.2337/dc07-0637 17595349
5. T Pischon F Hu K Rexrode C Girman J Manson E Rimm 2008 Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men Atherosclerosis 197 392 399 1:CAS:528:DC%2BD1cXisVSlsb4%3D 10.1016/j. atherosclerosis.2007.06.022 17681508
6. W Koenig N Khuseyinova J Baumert C Meisinger 2008 Prospective study of high sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998 Clin Chem 54 335 342 1:CAS:528:DC%2BD1cXhs1Cmu70%3D 10.1373/clinchem.2007.100271 18156284
7. P Ridker R Glynn C Hennekens 1998 C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction Circulation 97 2007 2011 1:STN:280:DyaK1c3nt1Slsg%3D%3D 9610529
8. J Yudkin I Juhan-Vague E Hawe S Humphries G di Minno M Margaglione, et al. 2004 Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study Metabolism 53 852 857 1:CAS:528:DC%2BD2cXlt1eltr8%3D 10.1016/j.metabol.2004.02.004 15254876
9. S Barnum J Volanakis 1989 Structure and function of C3 Year Immunol 6 208 228 2701904
10. T Scantlebury A Sniderman K Cianflone 2001 Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes Biochem Genet 356 445 452 1:CAS:528:DC%2BD3MXks1altbg%3D
11. S Meijssen H van Dijk C Verseyden D Erkelens M Cabezas 2002 Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia Arterioscler Thromb Vasc Biol 22 811 816 1:CAS:528: DC%2BD38XjslGmur8%3D 10.1161/01.ATV.0000014079.98335.72 12006395
12. A Hernández-Mijares M Jarabo-Bueno A López-Ruiz E Solá-Izquierdo C Morillas-Ariño M Martínez-Triguero 2007 Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors Int J Obes 31 927 932 10.1038/sj.ijo.0803543
13. S Mantov D Raev 1996 Additive effects of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis Int J Cardiol 56 145 148 1:STN:280:DyaK2s%2FltVSmtQ%3D%3D 10.1016/0167-5273(96)02706-4 8894785
14. G Engström B Hedblad K Eriksson L Janzon F Lindgärde 2005 Complement C3 is a risk factor for the development of diabetes: a population-based cohort study Diabetes Care 54 570 575
15. G Szeplaki Z Prohaszka J Duba S Rugonfalvi Kiss I Karadi M Kokai, et al. 2004 Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women Atherosclerosis 177 383 389 1:CAS:528: DC%2BD2cXpsFeqsbY%3D 10.1016/j.atherosclerosis.2004.07.022 15530914
16. A Carter U Prasad P Grant 2009 Complement C3 and C-reactive protein in male survivors of myocardial infarction Grant Atheroscler 203 538 543 1:CAS:528:DC%2BD1MXjslyitbY%3D 10.1016/j.atherosclerosis.2008.07.007
17. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Organisation, Geneva
18. B Williams N Poulter M Brown M Davis G Mclnnes J Potter, et al. 2004 British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary BMJ 328 634 640 10.1136/bmj.328.7440.634 15016698
19. D Matthews J Hosker A Rudenski B Naylor D Treacher R Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 1:CAS:528:DyaL2MXlslKnu7k%3D 10.1007/BF00280883 3899825
20. S Wannamethee G Lowe A Shaper A Rumley L Lennon P Whincup 2005 The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men Atherosclerosis 181 101 108 1:CAS:528:DC%2BD2MXltFWjs7c%3D 10.1016/j.atherosclerosis.2004.12.031 15939060
21. C Eklund 2009 Proinflammatory cytokines in CRP baseline regulation. Advances in clinical chemistry Adv Clin Chem 48 111 136 1:CAS:528: DC%2BD1MXhs1Wis7bF 10.1016/S0065-2423(09)48005-3 19803417
22. C Steppan M Lazar 2002 Resistin and obesity-associated insulin resistance Trends Endocrinol Metab 13 18 23 1:CAS:528:DC%2BD3MXpt1anurc%3D 10.1016/S1043-2760(01)00522-7 11750858
23. C Halkes H van Dijk P de Jaegere H Plokker Y van der Helm D Erkelens, et al. 2001 Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin Arterioscler Thromb Vasc Biol 21 1526 1530 1:CAS:528:DC%2BD3MXntVGrsrs%3D 10.1161/hq0901.095276 11557683
24. R Donahue J Bean R Donahue R Goldberg R Prineas 1997 Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami community health study Arterioscler Thromb Vasc Biol 17 2413 2417 1:STN:280:DyaK1c%2FntlKktg%3D%3D 9409209
25. A Muscari G Massarelli L Bastagli G Poggiopollini V Tomassetti G Drago, et al. 2000 Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men Eur Heart J 21 1081 1090 1:STN:280:DC%2BD3czpsFWltg%3D%3D 10.1053/euhj.1999.2013 10843826
26. C Weyer P Tataranni R Pratley 2000 Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration Diabetes Care 23 779 785 1:CAS:528:DC%2BD3cXnvV2is7c%3D 10.2337/diacare.23.6.779 10840996